Your browser doesn't support javascript.
loading
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation.
Thomenius, Michael J; Totman, Jennifer; Harvey, Darren; Mitchell, Lorna H; Riera, Thomas V; Cosmopoulos, Kat; Grassian, Alexandra R; Klaus, Christine; Foley, Megan; Admirand, Elizabeth A; Jahic, Haris; Majer, Christina; Wigle, Tim; Jacques, Suzanne L; Gureasko, Jodi; Brach, Dorothy; Lingaraj, Trupti; West, Kip; Smith, Sherri; Rioux, Nathalie; Waters, Nigel J; Tang, Cuyue; Raimondi, Alejandra; Munchhof, Michael; Mills, James E; Ribich, Scott; Porter Scott, Margaret; Kuntz, Kevin W; Janzen, William P; Moyer, Mikel; Smith, Jesse J; Chesworth, Richard; Copeland, Robert A; Boriack-Sjodin, P Ann.
Affiliation
  • Thomenius MJ; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Totman J; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Harvey D; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Mitchell LH; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Riera TV; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Cosmopoulos K; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Grassian AR; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Klaus C; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Foley M; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Admirand EA; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Jahic H; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Majer C; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Wigle T; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Jacques SL; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Gureasko J; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Brach D; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Lingaraj T; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • West K; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Smith S; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Rioux N; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Waters NJ; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Tang C; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Raimondi A; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Munchhof M; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Mills JE; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Ribich S; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Porter Scott M; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Kuntz KW; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Janzen WP; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Moyer M; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Smith JJ; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Chesworth R; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Copeland RA; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
  • Boriack-Sjodin PA; Epizyme, Inc., Cambridge, Massachusetts, United States of America.
PLoS One ; 13(6): e0197372, 2018.
Article in En | MEDLINE | ID: mdl-29856759
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Histone-Lysine N-Methyltransferase / Carcinogenesis / Adenocarcinoma of Lung Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Histone-Lysine N-Methyltransferase / Carcinogenesis / Adenocarcinoma of Lung Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos